References
1. Favorov M., Ali M., Tursunbayeva A., Aitmagambetova I., Kilgore P., Ismailov S., Chorba T. Comparative tuberculosis (TB) prevention effectiveness of Bacillus Calmette-Guerin (BCG) vaccines from different producers among children. PLOSONE 2012. URL:https://doi.org/10.1371/journal.pone.0032567
2. Belilovskiy E., Borisov S., Dadu A., Favorov M. Implementation of the Computerized TB Surveillance in National Tuberculosis program. Int J Tuberc Lung Dis. The 3rd Congress of IUATLD. European Regionю 14th National Congress on Lung Diseases. June, 2004. Moscow, Abstract book. Abstract #222.
3. Colditz G., Brewer T., Berkey C., Wilson M., Burdick E., Fineberg H. Efficacy of BCG Vaccine in the Prevention of Tuberculosis. Meta-analysis of published literature. JAMA. 1994. 271: 698-702.
4. URL: https://www.who.int/immunization/BCG_8May2008_RU.pdf ("BCG vaccine. WHO Position") (in Russian), date of reference 09.08.2019
5. Comstock G.W. Simple, practical ways to assess the protective efficacy of a new tuberculosis vaccine. Clin Infect Dis. 2000; 30 (Suppl 3): S250-3.
6. Romanus V. Tuberculosis in bacillus Calmette-Guerin immunized and non-immunized children in Sweden: a ten years evaluation following cessation of general bacillus Calmette-Guerin immunization of the newborn in 1975. Pediatr Infect Dis J. 1987; 6: 272-80.
7. Mackenzie R., Dixon A.K. Measuring the effects of imaging: an evaluative framework. Clin Radiol. 1995; 50 (8): 513-8.
8. https://www.healthcare-economist.com/2016/01/25/efficacy-vs-effectiveness-vs-efficiency/ (date of reference 09.08.2019)
9. Padungchan S., Konjanart S., Kasiratta S., Daramas S., ten Dam H.G. The effectiveness of BCG vaccination of the newborn against childhood tuberculosis in Bangkok. Bull World Health Organ. 1986; 64: 247-58.
10. Tidjani O., Amedome A., ten Dam H.G. The protective effect of BCG vaccination of the newborn against childhood tuberculosis in an African community. Tubercle. 1986; 67: 269-81.
11. Knowledge heals. 60 years of useless TB vaccination. https://glagolas.livejournal.com/126884.html (date of reference 09.08.2019) (in Russian)
12. WHO/UNICEF Review of National Immunization Coverage 19802007, Kazakhstan, 2008.
13. Statistical TB review for the Republic of Kazakhstan / Ed. Sh.Sh. Ismailova. Almaty; 2009: 65 p. (in Russian)
14. Agency on Statistics of Republic of Kazakhstan. http://www.stat.kz (in Russian)
15. Smith P.G., Morrow R.H. (eds.). Field trials of health interventions in developing countries. A Toolbox. 2nd ed. London: Macmillan Education Limited; 1996.
16. Belilovsky E.M., Borisov S.E., Rybka L.N. TB surveillance in the city of Moscow and prospects for its development. Tuberkulez i sotsial’no znachimye zabolevaniya [Tuberculosis and Socially Significant Diseases]. 2017; (1): 4-13. (in Russian)
17. Shapiro C., Cook N., Evans D., et al. A case-control study of BCG and childhood tuberculosis in Cali, Colombia. Int J Epidemiol. 1985; 14: 441-6.
18. Sirinavin S., Chotpitayasunondh T., Suwanjutha S., Sunakorn P., Chantarojanasiri T. Protective efficacy of neonatal Bacillus Calmette-Guerin vaccination against tuberculosis. Pediatr Infect Dis J. 1991; 10: 359-65.
19. Comstock G.W. Field trials of tuberculosis vaccines: how could we have done them better? Control Clin Trials. 1994; 15: 247-76.
20. von Reyn C.F. Routine childhood Bacillus Calmette-Guerin immunization and HIV infection. Clin Infect Dis. 2006; 42: 559-61.
21. Favorov M., Belilovsky E., Aitmagambetova I., Ismailov S., White M. E., Chorba T. Tuberculosis deaths averted by implementation of the DOTS strategy in Kazakhstan. Int J Tuberc Lung Dis. 2010; 14 (12): 1582-8.
22. Aksenova V.A., Baryshnikova L.A., Sevostyanova T.A., Klevno N.I. Tuberculosis in children in Russia and the objectives of the TB service and general pediatric service for the prevention and early detection of disease. Tuberkulez i bolezni legkikh [Tuberculosis and Lung Disease]. 2014; (3): 40-6. (in Russian)
23. Fine PE. BCG vaccination against tuberculosis and leprosy. Br Med Bull. 1988; 44: 691-703.
24. Rodrigues L.C., Diwan V.K., Wheeler J.G. Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis. Int J Epidemiol. 1993; 22 (6): 1154-8.
25. Mangtani P., Abubakar I., Ariti C., Beynon R., Pimpin L., Fine P.E.M., et al. Protection by BCG vaccine against tuberculosis: A systematic review of randomized controlled trials. Clin Infect Dis. 2014;58 (4): 470-80.
26. Belilovsky E.M., Kochetkova E.Ya., Seltsovsky P.P., Kotova E.A., Rybka L.N., Rostovtsev S.A., et al. TB incidence in Moscow. In: TB control in the city of Moscow. Analytical review of statistical indicators for tuberculosis. 2017, ed. by Bogorodskaya E.M., Litvinov V.I., Belilovsky E.M. Moscow: MNPTSBT; 2018: 33-66. (in Russian)
27. Ilchenko A.D., Bogorodskaya E.M., Mokhireva L.V. Organization of TB care for the homeless, foreign and nonresident citizens in the city of Moscow. In: TB control in the city of Moscow. Analytical review of statistical indicators for tuberculosis. 2017, ed. by Bogorodskaya E.M., Litvinov V.I., Belilovsky E.M. Moscow: MNPTSBT; 2018: 207-52. (in Russian)
28. Fine P.E. BCG: the challenge continues. Scand J Infect Dis. 2001; 33: 243-5.
29. Delogu G., Fadda G. The quest for a new vaccine against tuberculosis. J Infect Dev Ctries. 2009; 3: 5-15.
30. Behr M.A., Wilson M.A., Gill W.P., et al. Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science. 1999; 284: 1520-3.
31. Brosch R., Gordon S.V., Garnier T., et al. Genome plasticity of BCG and impact on vaccine efficacy. Proc Natl Acad Sci. USA. 2007; 104: 5596-601.
32. Svenson S., Kallenius G., Pawlowski A., Hamasur B. Towards new tuberculosis vaccines. Hum Vaccin. 2010; 6: 309-17.
33. Russell D.G., Barry C.E. 3rd, Flynn J.L. Tuberculosis: What we don’t know can, and does, hurt us. Science. 2010; 328: 852-6.